RANBP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.060400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.336400E-01
Normal-vs-Stage2
2.929400E-01
Normal-vs-Stage3
1.892440E-01
Normal-vs-Stage4
2.488000E-01
Stage1-vs-Stage2
1.762590E-01
Stage1-vs-Stage3
1.197780E-02
Stage1-vs-Stage4
6.604600E-01
Stage2-vs-Stage3
1.080380E-03
Stage2-vs-Stage4
4.941400E-01
Stage3-vs-Stage4
2.308400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.075400E-01
Normal-vs-AfricanAmerican
1.779950E-01
Normal-vs-Asian
2.432200E-01
Caucasian-vs-AfricanAmerican
6.507600E-01
Caucasian-vs-Asian
2.111800E-01
AfricanAmerican-vs-Asian
1.722170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.011600E-01
Normal-vs-Female
3.156000E-01
Male-vs-Female
6.326400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.464600E-01
Normal-vs-Age(41-60Yrs)
3.394600E-01
Normal-vs-Age(61-80Yrs)
2.954200E-01
Normal-vs-Age(81-100Yrs)
2.724800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.930600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.664000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.724600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.137400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.176600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.662400E-01
Normal-vs-Daily Drinker
2.322200E-01
Normal-vs-Weekly Drinker
5.911900E-02
Normal-vs-Occasional Drinker
3.301800E-01
Normal-vs-Social Drinker
7.184200E-02
Non Drinker-vs-Daily Drinker
3.597400E-01
Non Drinker-vs-Weekly Drinker
3.650600E-01
Non Drinker-vs-Occasional Drinker
2.428800E-01
Non Drinker-vs-Social Drinker
1.691210E-01
Daily Drinker-vs-Weekly Drinker
1.477770E-01
Daily Drinker-vs-Occasional Drinker
7.765700E-02
Daily Drinker-vs-Social Drinker
6.216300E-02
Weekly Drinker-vs-Occasional Drinker
9.202200E-01
Weekly Drinker-vs-Social Drinker
7.429200E-01
Occasional Drinker-vs-Social Drinker
7.851000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.327400E-01
Normal-vs-Grade 2
7.900600E-01
Normal-vs-Grade 3
7.936800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.267200E-01
Grade 1-vs-Grade 3
4.145000E-01
Grade 1-vs-Grade 4
4.327400E-01
Grade 2-vs-Grade 3
9.550000E-01
Grade 2-vs-Grade 4
7.900600E-01
Grade 3-vs-Grade 4
7.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.791800E-01
Normal-vs-NonDiabetic
2.978600E-01
Diabetic-vs-NonDiabetic
5.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.255600E-01
Normal-vs-NoPancreatitis
2.958400E-01
Pancreatitis-vs-NoPancreatitis
1.163350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.193600E-01
Normal-vs-N1
3.007400E-01
N0-vs-N1
6.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.804600E-01
Normal-vs-TP53-NonMutant
4.025400E-01
TP53-Mutant-vs-TP53-NonMutant
1.375520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
